查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球脂肪酶市場 - 2023-2030
市場調查報告書
商品編碼
1418684

全球脂肪酶市場 - 2023-2030

Global Lipase Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年全球脂肪酶市場規模達7.2912億美元，預計2030年將達到1,2094.1億美元，2023-2030年預測期間CAGR為6.53%。

人們對健康和保健意識的不斷增強正在推動對特定膳食脂肪酶產品的需求。脂肪酶用於生產低脂肪和低膽固醇食品。隨著越來越多的消費者尋求更健康的食品選擇，這一趨勢預計將繼續對脂肪酶市場產生積極影響。清潔標籤和植物性食品運動正在影響脂肪酶市場，促使製造商尋求符合這些趨勢的酵素。

歐洲對含有天然成分的清潔標籤產品的需求正在激增。這一趨勢正在推動脂肪酶在食品和飲料製造中作為清潔標籤酶的使用。製造商正在從非基因改造生物（non-GMO）和其他天然來源中尋找脂肪酶，以滿足消費者的喜好，擴大市場。

例如，2022年11月8日，帝斯曼推出了四項創新解決方案，旨在最大限度地提高原料的性能。其中一項創新 Panamore Xtense 是在 FiE 上推出的。這種標籤友善脂肪酶可作為常用乳化劑 DATEM 的永續替代品。它透過增強麵團穩定性並最佳化體積和形狀，為麵包生產商提供了顯著的優勢。

動力學

對加工食品不斷成長的需求

加工食品消費量的增加刺激了食品加工各階段對脂肪酶等酵素的需求。脂肪酶在將脂肪分解為脂肪酸和甘油方面發揮著重要作用，使其在食品製造中不可或缺。脂肪酶幫助食品公司增強加工食品的風味。這導致零食和即食食品的生產品質得到改善，對消費者更具吸引力。

脂肪酶正在為延長保存期限食品的開發做出貢獻。透過分解脂肪，它有助於減少酸敗並延長加工食品的壽命，解決製造商和消費者的關鍵問題。食品業正在見證多樣化加工食品的發展激增，推動市場成長。

健康意識不斷增強的消費者

注重健康的消費者正在積極尋找更健康的食品選擇。這一趨勢推動了低脂肪和低熱量食品生產中對脂肪酶的需求，與注重更好營養和體重管理的飲食偏好相一致。脂肪酶用於降低加工食品的脂肪含量而不影響味道。注重健康的人喜歡脂肪含量較低的食品，這是推動市場成長的因素。

根據胰臟癌行動網報道，2022 年 7 月 5 日，美國食品藥物管理局 (FDA) 建議個人在食用零食時開始服用 10,000 - 20,000 個脂肪酶單位，隨餐服用 20,000 - 40,000 個脂肪酶單位。假設每天總共四餐，患者必須遵守每餐每公斤體重不超過 2,500 脂肪酶單位的指導方針。

生產成本高

脂肪酶製造過程中的高生產成本導致市場上營運的公司的利潤率下降。這種有限的獲利能力阻礙了市場成長，因為它限制了可用於研發、行銷和擴張的資源。高生產成本通常會導致脂肪酶產品價格上漲，從而限制市場成長。

高生產成本的負擔對於在脂肪酶市場營運的中小型企業（SME）來說尤其具有挑戰性。這些公司在保持有競爭力的定價方面面臨困難，這限制了它們的市場成長潛力。高生產成本為希望投資脂肪酶市場的新進業者和新創公司設置了障礙。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 來源片段
  • 按表格列出的片段
  • 按應用程式片段
  • 按地區分類的片段

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 對加工食品不斷成長的需求
      • 健康意識不斷增強的消費者
    • 限制
      • 生產成本高
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按來源

  • 微生物
  • 動物
  • 植物

第 8 章：按形式

  • 液體
  • 粉末

第 9 章：按應用

  • 乳製品
  • 麵包店和糖果店
  • 動物飼料
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • Koninklijke DSM NV
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Novozymes A/S
  • Clerici-Sacco Group
  • Renco New Zealand
  • Enzyme Development Corporation
  • Chr. Hansen Holdings A/S
  • Amano Enzymes Inc.
  • Associated British Foods PLC
  • International Flavors & Fragrances Inc.
  • Advanced Enzyme Tech

第 13 章：附錄

簡介目錄
Product Code: FB7749

Overview

Global Lipase Market reached US$ 729.12 million in 2022 and is expected to reach US$ 1209.41 billion by 2030, growing with a CAGR of 6.53% during the forecast period 2023-2030.

Growing awareness of health and wellness is driving the demand for specific dietary lipase products. Lipases are used in the production of low-fat and low-cholesterol food items. As more consumers seek healthier food choices, this trend is expected to continue influencing the lipase market positively. The clean-label and plant-based food movements are influencing the lipase market, prompting manufacturers to seek enzymes that align with these trends.

Europe is experiencing a surge in demand for clean-label products with natural ingredients. This trend is propelling the utilization of lipases as clean-label enzymes in food and beverage manufacturing. Manufacturers are seeking lipases from non-genetically modified organisms (non-GMO) and other natural sources to meet consumer preferences, expanding the market.

For instance, on November 8, 2022, DSM introduced four innovative solutions aimed at maximizing the performance of raw materials. One of these innovations, Panamore Xtense, was launched at FiE. This label-friendly lipase serves as a sustainable substitute for the commonly used emulsifier DATEM. It offers significant advantages to bread producers by enhancing dough stability and optimizing volume and shape.

Dynamics

Growing Demand for Processed Food

The rising consumption of processed foods is stimulating the need for enzymes like lipase in various stages of food processing. Lipase plays a role in breaking down fats into fatty acids and glycerol, making it indispensable in food manufacturing. Lipase helps food companies enhance the flavor profiles of processed foods. This is leading to the production of snacks and ready-to-eat meals with improved taste, making them more appealing to consumers.

Lipase is contributing to the development of food products with extended shelf life. By breaking down fats, it helps reduce rancidity and improves the longevity of processed food items, addressing a critical concern for both manufacturers and consumers. The food industry is witnessing a surge in the development of diverse processed food products, driving market growth.

Rising Health-Conscious Consumers

Health-conscious consumers are actively seeking out healthier food options. This trend drives the demand for lipase in the production of low-fat and low-calorie food products, aligning with dietary preferences are focusing on better nutrition and weight management. Lipase enzymes are used to reduce the fat content of processed foods without compromising taste. Health-conscious individuals prefer food items with lower fat content, which are factors driving market growth.

According to the Pancreatic Cancer Action Network, on July 5, 2022, the United States Food and Drug Administration (FDA) recommends that individuals begin with a dosage of 10,000 - 20,000 lipase units when consuming snacks and 20,000 - 40,000 lipase units with meals. Patients must adhere to the guideline of not surpassing 2,500 lipase units per kilogram of body weight per meal, assuming a total of four meals per day.

High Production Costs

High production costs in the lipase manufacturing process are leading to reduced profit margins for companies operating in the market. This limited profitability is hindering market growth, as it is constraining resources available for research and development, marketing, and expansion. High production costs often translate into higher prices for lipase-based products, restraining market growth.

The burden of high production costs is particularly challenging for small and medium-sized enterprises (SMEs) operating in the lipase market. These companies are facing difficulties in maintaining competitive pricing, which limits their market growth potential. High production costs are creating barriers for new entrants and startups looking to invest in the lipase market.

Segment Analysis

The global lipase market is segmented based on source, form, application, and region.

Growing Availability, Cost-Effectiveness, and Versatility of Microbial Lipase

The microbial segment held the largest share of the global lipase market. Microbial lipases are derived from microorganisms like bacteria and fungi. It is produced on a large scale, and this widespread availability ensures a stable supply for the market. Microbial lipases are a cost-effective choice for many industries. Their efficient production costs make them an attractive option for various applications.

Microbial lipases display versatility in their catalytic activities, making them suitable for a wide range of applications. This adaptability allows them to serve multiple sectors, such as food and biofuels. Manufacturers and researchers are focusing on enhancing the properties of microbial lipases to meet specific industrial needs. These tailored solutions cater to the diverse requirements of different applications.

Geographical Penetration

Robust Industrial Presence, Diverse Applications in Europe

Europe held the dominant position in the global lipase market. Europe has a strong, well-established food sector in countries such as Germany, France, and Italy, which is contributing significantly to the growth of the lipase market in the region. Europe is maintaining stringent quality and safety standards for the production and application of lipases in various sectors. This commitment to quality and compliance is enhancing the trust of consumers and industries in lipase products.

Lipase enzymes find applications in a wide range of sectors, from the food and pharmaceutical industries to biotechnology. The diversity of applications is allowing Europe to cater to a broad customer base. European companies are continually introducing innovative lipase products tailored to specific industry needs. This product innovation is helping them maintain a strong foothold in the market.

For instance, on May 29, 2020, Biocatalysts Ltd, specialists in enzymes, introduced its latest enzyme, Lipomod 767P. This non-genetically modified microbial lipase preparation is well-suited for both the hydrolysis and esterification of oils and fats. Its wide-ranging pH compatibility allows for use across various substrate types. Lipomod 767P offers the capability to selectively hydrolyze triglycerides, releasing free fatty acids.

COVID-19 Impact Analysis:

The global lipase market faced supply chain disruptions due to lockdowns, restrictions, and transportation challenges, which have affected the timely availability of lipase products in the market. Lipase has applications in various end-user industries, including food, pharmaceuticals, and research. The disruptions in these sectors negatively affected the overall market as businesses scaled back production and research activities.

However, the lipase market experienced growth in the pharmaceutical sector as lipase enzymes played a role in potential treatments or vaccines for COVID-19. This led to increased research and development activities in the pharmaceutical market segment. The pandemic accelerated the adoption of e-commerce and home cooking. As a result, there was increased demand for lipase in consumer-friendly formats for baking and cooking, which benefited the market.

Russia-Ukraine War Impact Analysis

The lipase market has relied on a steady supply of raw materials. The geopolitical tension between Russia and Ukraine led to uncertainties in the sourcing of essential raw materials, which negatively impacted production. The lipase market experienced supply chain disruptions as the conflict disrupted transportation routes and logistics networks. This hampered the timely delivery of lipase products to various regions.

The conflict prompted greater emphasis on sustainability and self-sufficiency in various industries. This shift towards sustainability has driven innovation and growth in the lipase market as consumers and industries have sought more sustainable products. In response to the geopolitical tensions, players in the lipase market explored diversifying their supply sources to mitigate risks associated with dependency on specific regions.

By Source

  • Microbial
  • Animal
  • Plant

By Form

  • Liquid
  • Powder

By Application

  • Dairy
  • Bakery and Confectionery
  • Animal Feed
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On August 31, 2023, Alcresta Therapeutics, Inc., a prominent company specializing in the development and commercialization of innovative enzyme-based products, announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the extended use of RELiZORB in children aged 2 to under 5 years. RELiZORB is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase.
  • On February 25, 2020, Researchers from the University of Portsmouth, in collaboration with an international team, created an enzyme derived from agricultural waste. This enzyme, produced from a by-product of mustard seeds, has the potential to become a valuable additive in laundry detergents. The aim is to develop an economical, naturally sourced alternative to lipase, the second most widely produced enzyme on the market.
  • On December 18, 2023, Zomedica Corp. introduced three new assays - Canine Pancreatic Lipase (cPL), Cobalamin (B12), and Folate - for the TRUFORMA In-Clinic Biosensor Testing Platform.

Competitive Landscape

The major global players in the lipase market include: Koninklijke DSM N.V., Novozymes A/S, Clerici-Sacco Group, Renco New Zealand, Enzyme Development Corporation, Chr. Hansen Holdings A/S, Amano Enzymes Inc., Associated British Foods PLC, International Flavors & Fragrances Inc., and Advanced Enzyme Tech.

Why Purchase the Report?

  • To visualize the global lipase market segmentation based on source, form, application, and region, as well as understand critical commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous lipase market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of critical products of all the major players.

The global lipase market report would provide approximately 61 tables, 57 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Form
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Demand for Processed Food
      • 4.1.1.2. Rising Health-Conscious Consumers
    • 4.1.2. Restraints
      • 4.1.2.1. High Production Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Source

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 7.1.2. Market Attractiveness Index, By Source
  • 7.2. Microbial*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Animal
  • 7.4. Plant

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Liquid*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Powder

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Dairy*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Bakery and Confectionery
  • 9.4. Animal Feed
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Koninklijke DSM N.V*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Novozymes A/S
  • 12.3. Clerici-Sacco Group
  • 12.4. Renco New Zealand
  • 12.5. Enzyme Development Corporation
  • 12.6. Chr. Hansen Holdings A/S
  • 12.7. Amano Enzymes Inc.
  • 12.8. Associated British Foods PLC
  • 12.9. International Flavors & Fragrances Inc.
  • 12.10. Advanced Enzyme Tech

LIST NOT EXHAUSTIVE.

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us